People with diabetes and kidney disease will soon be able to enjoy the taste of potatoes. Experts have completed their research on the vegetable. Through genetic modification, the potato's glycaemic index is being improved. Elements such as carbohydrates have been reduced, which will lessen the impact of potato consumption on various diseases. This has improved the potato's glycaemic index, slowing the rate at which glucose is released. The carbohydrate level is also lower. As a result, people with diabetes, kidney disease, and obesity will be able to consume potatoes normally. The potato will also be a low-calorie food.
The Science: TPS Diploid Method Vs. Tetraploid Tubers
Now, the potato crop will be grown from its seed using the TPS diploid method, instead of from tubers. Until now, new potato crops have been grown by planting tubers in the ground. These tubers are produced using the tetraploid method, meaning their genes contain four sets of chromosomes. In such cases, the traits of the older variety are inevitably passed on through at least one of the chromosomes. CPRI will now develop the potato using the diploid method instead of the tetraploid one. This change means its genes will have two sets of chromosomes, which experts can easily control. It is easier to control the potato's chromosomes in the seed. As a result, the traditional properties of the potato have been modified.
Availability And CPRI Research
The Central Potato Research Institute (CPRI), the central body for potato research, has developed the seed and has already cultivated a crop from it. The Central Potato Research Institute (CPRI) has completed its research on this. This potato seed will be made available to farmers this year. There is often a risk of various viruses and diseases spreading from potato seeds.